- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare DSP Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.93 | 1.94 |
NAV | ₹36.16 | ₹34.77 |
Fund Started | 12 Nov 2018 | 25 Jun 2018 |
Fund Size | ₹2950.74 Cr | ₹4611.47 Cr |
Exit Load | Exit load of 0.50% if redeemed within 1 month. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.93
1.94
NAV
₹36.16
₹34.77
Fund Started
12 Nov 2018
25 Jun 2018
Fund Size
₹2950.74 Cr
₹4611.47 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 14.39% | 19.12% |
3 Year | 18.67% | 21.70% |
5 Year | 26.65% | 28.26% |
1 Year
14.39%
19.12%
3 Year
18.67%
21.70%
5 Year
26.65%
28.26%
Holding Analysis
Equity | 97.59% | 99.04% |
Cash | 2.41% | 0.96% |
Equity
97.59%
99.04%
Cash
2.41%
0.96%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Suven Pharmaceuticals Ltd. | 10.25% |
Sun Pharmaceutical Industries Ltd. | 10.13% |
Cipla Ltd. | 8.54% |
Ipca Laboratories Ltd. | 7.37% |
Globus Medical Inc | 6.39% |
Gland Pharma Ltd. | 4.84% |
Illumina Inc. (USA) | 4.22% |
Apollo Hospitals Enterprise Ltd. | 4.00% |
Laurus Labs Ltd. | 3.96% |
Sai Life Sciences Ltd. | 3.73% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.21% |
Cipla Ltd. | 9.55% |
Dr. Reddy's Laboratories Ltd. | 8.94% |
Divi's Laboratories Ltd. | 6.78% |
Aurobindo Pharma Ltd. | 5.15% |
Lupin Ltd. | 4.73% |
Alkem Laboratories Ltd. | 4.49% |
Gland Pharma Ltd. | 3.52% |
Zydus Lifesciences Ltd. | 3.27% |
Mankind Pharma Ltd. | 2.85% |
Fund Manager
Name | Jay Kothari | Dharmesh Kakkad |
Start Date | 16 Mar 2018 | 23 Feb 2021 |
Name
Jay Kothari
Dharmesh Kakkad
Start Date
16 Mar 2018
23 Feb 2021
About Fund
Description | The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 12 Nov 2018 | 25 Jun 2018 |
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
12 Nov 2018
25 Jun 2018